Valproic acid dosage and plasma protein binding and clearance

Area of Science:

• Pharmacokinetics
• Drug Metabolism
• Clinical Pharmacology

Background:

• Valproic acid is an antiepileptic drug with variable pharmacokinetics.
• Understanding dose-dependent clearance is crucial for optimizing therapeutic efficacy and safety.

Purpose of the Study:

• To investigate the dose-dependent changes in valproic acid clearance and protein binding in healthy subjects.
• To explore the relationship between dose, free fraction, and intrinsic clearance of valproic acid.

Main Methods:

• Single and multiple oral doses of valproic acid (250 mg to 1,500 mg/day) were administered to six healthy subjects.
• Valproate levels and protein binding were measured at steady state.
• Clearance and free fraction were calculated at different dosing levels.

Main Results:

• Valproic acid clearance decreased by 20% from single-dose to 500 mg/day (p=0.05).
• Despite increased free fraction at 1,000 mg/day, intrinsic clearance declined (p<0.05), indicating autoinhibition or saturation.
• Clearance increased at 1,500 mg/day, correlating with further increases in free fraction.

Conclusions:

• Valproic acid exhibits dose-dependent pharmacokinetics, with evidence of autoinhibition or saturation of metabolism at higher doses.
• Significant variability in free fraction within dosing intervals necessitates careful monitoring.
• These findings have implications for therapeutic drug monitoring and dose individualization of valproic acid.